Emotion Regulation, Psychosis, Recovery
Conditions
Keywords
Psychosis, Emotional regulation, Recovery
Brief summary
Our study aims to assess the efficacy of Acceptance and Commitment Therapy on psychotic severity among Inpatients with primary psychosis: A Randomized Controlled Trial.
Detailed description
Current study was an open label, two-arm, parallel, randomized controlled trial, evaluating the efficiency of Acceptance and Commitment Therapy (ACT) added to treatment as usual (TAU) as opposed to treatment as usual (TAU) alone on patients with schizophrenia. The study adheres to the rules for writing Clinical Trials: The Consolidated Standards of Reporting Trials (CONSORT) statement
Interventions
BEHAVIORALAcceptance and commitment therapy
The psychoeducational intervention will consist of seven structured sessions aimed at introducing patients with primary psychosis to the principles and practices of Acceptance and Commitment Therapy (ACT). The primary focus of the intervention is to empower participants to effectively manage distressing thoughts and feelings while pursuing meaningful and valued life goals. Each session covers specific aspects of ACT. Acceptance and commitment therapy will be adminitered in addition to treament as usual provided to patients.
COMBINATION_PRODUCTTreatment as usual
The treatment as usual (TAU) for all patients regardless of condition will consist of hospital treatment, including daily medication management sessions with a psychiatrist (e.g., antipsychotic and other medications as appropriate), community meetings, other group therapy, case management, occupational therapy, open air walks, discharge planning, physical examination, and other services (e.g., medical testing).
Sponsors
Port Said University
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE
Masking description
Information is not withheld from trial participants
Intervention model description
Current study is an open label, two-arm, parallel, randomized controlled trial, evaluating the efficiency of Acceptance and Commitment Therapy (ACT) added to treatment as usual (TAU) as opposed to treatment as usual (TAU) alone on patients with schizophrenia. The study adheres to the rules for writing Clinical Trials: The Consolidated Standards of Reporting Trials (CONSORT) statement
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
Participants' criteria of inclusion involved those patients who were 1. Current psychiatric hospitalization; 2. DSM-5 diagnosis of a primary psychotic disorder; (schizophrenia, schizoaffective disorder, delusional disorder, schizophreniform disorder, brief psychotic disorder, and unspecified psychotic disorder, this diagnosis was confirmed by a psychiatrist 3. 18 years or older; 4. ability to talk, read and write in Arabic; and 5. willingness to participate in the study that was scheduled for seven weeks.
Exclusion criteria
Patients were excluded if they 1. had a comorbid learning disability or organic brain disorder; 2. psychosis related to a general medical condition or substance-induced psychotic disorder; 3. were considered mentally unstable; or 4. unfit to participate in the study by their therapist, and/or had newly had (been receiving) psycho-education or somewhat designed psychosocial intervention.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Positive and Negative Syndrome Scale (PANSS) | 7 weeks | Measuring symptom severity of patients with schizophrenia. This is a 30-item instrument. Rating of each item is from (one, no evidence) to (seven, strong evidence) and the total score for overall psychopathology ranges from 30 to 210. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Difficulties in Emotion Regulation Scale | 7 weeks | A 36 item measure assesses individuals' typical levels of difficulties in emotion regulation |
| Recovery Assessment Scale | 7 weeks | 38 items scale evaluate mental health recovery |
Countries
Egypt
Outcome results
None listed